Cargando…
Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191994/ https://www.ncbi.nlm.nih.gov/pubmed/34111166 http://dx.doi.org/10.1371/journal.pone.0252785 |
_version_ | 1783705964417908736 |
---|---|
author | de Araújo, Lorena Maria Lima de Moura Lopes, Maria Vivyanne de Arruda, Rafael Silva Martins, Rand Randall Oliveira, Antonio Gouveia |
author_facet | de Araújo, Lorena Maria Lima de Moura Lopes, Maria Vivyanne de Arruda, Rafael Silva Martins, Rand Randall Oliveira, Antonio Gouveia |
author_sort | de Araújo, Lorena Maria Lima |
collection | PubMed |
description | AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. RESULTS: Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01–1.05), body mass index (OR 1.07 CI95% 1.01–1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20–8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39–8.88). CONCLUSION: PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent. |
format | Online Article Text |
id | pubmed-8191994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81919942021-06-10 Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use de Araújo, Lorena Maria Lima de Moura Lopes, Maria Vivyanne de Arruda, Rafael Silva Martins, Rand Randall Oliveira, Antonio Gouveia PLoS One Research Article AIM: To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. METHODOLOGY: This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. RESULTS: Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01–1.05), body mass index (OR 1.07 CI95% 1.01–1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20–8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39–8.88). CONCLUSION: PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent. Public Library of Science 2021-06-10 /pmc/articles/PMC8191994/ /pubmed/34111166 http://dx.doi.org/10.1371/journal.pone.0252785 Text en © 2021 de Araújo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article de Araújo, Lorena Maria Lima de Moura Lopes, Maria Vivyanne de Arruda, Rafael Silva Martins, Rand Randall Oliveira, Antonio Gouveia Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title | Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title_full | Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title_fullStr | Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title_full_unstemmed | Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title_short | Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use |
title_sort | proton pump inhibitor and community pharmacies: usage profile and factors associated with long-term use |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191994/ https://www.ncbi.nlm.nih.gov/pubmed/34111166 http://dx.doi.org/10.1371/journal.pone.0252785 |
work_keys_str_mv | AT dearaujolorenamarialima protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse AT demouralopesmariavivyanne protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse AT dearrudarafaelsilva protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse AT martinsrandrandall protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse AT oliveiraantoniogouveia protonpumpinhibitorandcommunitypharmaciesusageprofileandfactorsassociatedwithlongtermuse |